Skip to content
Channels - Discovery of a novel Keap1 inhibitor for neurodegeneration through virtual screening and molecular dynamics simulations :: FRELIP Discovery
Channels
Discovery of a novel Keap1 inhibitor for neurodegeneration through virtual screening and molecular dynamics simulations
Computational screening of natural inhibitors against Plasmodium falciparum kinases: Toward novel antimalarial therapies
The effect of lidocaine on apoptotic neurodegeneration in the developing mouse brain
IL-22 inhibits ferroptosis and attenuates ischemia-reperfusion-induced acute kidney injury: Association with activation of the P62-Keap1-Nrf2 signaling pathway
Virtual Screening, Toxicity Evaluation and Pharmacokinetics of Erythrina Alkaloids as Acetylcholinesterase Inhibitor Candidates from Natural Products
Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer’s management
Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Series of Bis-1,2,4-Triazoles as Thymidine Phosphorylase Inhibitor
Retraction: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
In Silico Discovery of 1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors for Breast Cancer Liver Metastasis via QSAR modeling, Molecular Docking, ADMET, and DFT Studies
Novel laccases for synthetic dye pollution mitigation-screening, statistical optimization and molecular characterization
Retraction: Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets
Expression of Concern: The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination
Binding Analysis Using Accelerated Molecular Dynamics Simulations and Future Perspectives
BEDB: a comprehensive binding energy database for molecular docking and dynamics: insights into Human Metapneumovirus (HMPV) Inhibitors
Retraction: Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery
Correction: The relationship between screen time, screen content for children aged 1–3, and the risk of ADHD in preschools
Molecular aspects of SGLT2 inhibitor interactions in myocardial failure
Protective effects of the natural polyphenol garcinol from Garcinia indica mitigates aluminium chloride-induced Alzheimer’s-like neurodegeneration in
Deciphering the molecular network of Trichostatin A in regulating Alzheimer’s disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation
Global profiling of α-glucosidase inhibitors from Citri Reticulatae Pericarpium based on affinity ultrafiltration screening coupled with UPLC-ESI-Orbitrap-MS method
Ro5‐4864, a ligand of the mitochondrial translocator protein, protects against heart failure in mice via regulation of the p62‐Keap1‐Nrf2 axis
A novel multi objective grey wolf optimization fuzzy miner for process discovery: Incorporating robustness and explainability in model evaluation
Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406
Structural engineering, BSA binding and computational analysis of isonipacotate based enzyme inhibitors containing 1,2,4-triazole
Elucidation of Molecular Interactions Between Drug–Polymer in Amorphous Solid Dispersion by a Computational Approach Using Molecular Dynamics Simulations